Featured News

The Celiac Disease Foundation, is proud to announce a recent grant of $200,000 from the Foster Family Foundation, which CDF will use to further its mission.

The Celiac Disease Foundation today announces the departure of Chief Development Officer Deborah Ceizler, who has served in key roles for more than 18 years.

During May, Celiac Disease Awareness Month, the Celiac Disease Foundation wants to take this opportunity to honor the advocacy efforts of our dedicated, inspiring celiac disease patient community.

The Celiac Disease Foundation is proud to continue our partnership with the Celiac Disease Center at Columbia University in presenting an annual free livestream international symposium, this year titled "Celiac Disease: On the Horizon". Registration open now.

As part of our rapidly expanding efforts to secure a clear path for the development of treatments and funding for celiac disease at the federal level, we are pleased to…

A new report released by an international group of researchers finds that pediatric celiac disease varies by region, and recommends a “low threshold for screening and further research on region-specific celiac disease triggers.”

The Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.

The month of May is Celiac Disease Awareness Month, and in an effort to bring celiac disease into the public eye, Marilyn G. Geller, Chief Executive Officer of the Celiac…

Marilyn G. Geller, Chief Executive Officer of the Celiac Disease Foundation, was recently interviewed by the Jewish Journal, the largest weekly Jewish newspaper in the United States, to draw attention to this serious and severely underdiagnosed disease.  

We are pleased to announce that CDF Board Member, Kristin Yarema, PhD, was honored as a 2022 Medical Marketing & Media Woman of Distinction.